ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · IEX Real-Time Price · USD
-0.007 (-4.12%)
At close: Apr 19, 2024, 4:00 PM
+0.005 (2.84%)
After-hours: Apr 19, 2024, 7:54 PM EDT

ReShape Lifesciences Market Cap

ReShape Lifesciences has a market cap or net worth of $3.88 million as of April 19, 2024. Its market cap has decreased by -9.83% in one year.

Market Cap
Enterprise Value
1-Year Change
Stock Price

Market Cap Chart

Since October 6, 2016, ReShape Lifesciences's market cap has decreased from $239.30M to $3.88M, a decrease of -98.38%. That is a compound annual growth rate of -42.12%.


DateMarket Cap% Change
Apr 19, 20243.90M-2.50%
Apr 18, 20244.00M5.26%
Apr 17, 20243.80M-
Apr 16, 20243.80M-
Apr 15, 20243.80M-2.56%
Apr 12, 20243.90M2.63%
Apr 11, 20243.80M-2.56%
Apr 10, 20243.90M-4.88%
Apr 9, 20244.10M5.13%
Apr 8, 20243.90M-
Apr 5, 20243.90M-2.50%
Apr 4, 20244.00M-2.44%
Apr 3, 20244.10M2.50%
Apr 2, 20244.00M5.26%
Apr 1, 20243.80M58.33%
Mar 28, 20242.40M-
Mar 27, 20242.40M-
Mar 26, 20242.40M-4.00%
Mar 25, 20242.50M4.17%
Mar 22, 20242.40M4.35%
Mar 21, 20242.30M-
Mar 20, 20242.30M9.52%
Mar 19, 20242.10M-4.55%
Mar 18, 20242.20M4.76%
Mar 15, 20242.10M-4.55%
View and export this data all the way back to 2016. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Tharimmune 4.44M
Genprex 4.24M
Artelo Biosciences 4.13M
INVO Bioscience 4.11M
Evoke Pharma 4.06M
NexImmune 3.90M
Mustang Bio 3.85M
iSpecimen 3.83M
Market Cap Rankings